Patents by Inventor Fiona McNae

Fiona McNae has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Test methods, devices and test kits
    Publication number: 20070015285
    Abstract: A method for determining the time of maximum fertility in the mammalian ovulation cycle, for the purpose of assisting conception, wherein testing is conducted over a period of days in the current ovulation cycle on samples of body fluid obtained from an individual human subject to detect an elevated concentration of first analyte, such as luteinising hormone (LH) indicative of the event of ovulation, and additionally testing is conducted over a period of days in the current ovulation cycle on samples of body fluid obtained from the individual subject to detect an elevated concentration of a second analyte, such as estradiol or a metabolite thereof, especially estradiol-3-glucuronide (E3G), to provide advance warning of ovulation.
    Type: Application
    Filed: May 16, 2006
    Publication date: January 18, 2007
    Applicant: Inverness Medical Switzerland GmbH/Unipath
    Inventors: Michael Catt, Rosie Habeshaw, Keith May, Fiona McNae, Andrew Phelan
  • Test methods, devices and test kits
    Patent number: 7044919
    Abstract: A method for determining the time of maximum fertility in the mammalian ovulation cycle, for the purpose of assisting conception, wherein testing is conducted over a period of days in the current ovulation cycle on samples of body fluid obtained from an individual human subject to detect an elevated concentration of first analyte, such as luteinising hormone (LH) indicative of the event of ovulation, and additionally testing is conducted over a period of days in the current ovulation cycle on samples of body fluid obtained from the individual subject to detect an elevated concentration of a second analyte, such as estradiol or a metabolite thereof, especially estradiol-3-glucuronide (E3G), to provide advance warning of ovulation.
    Type: Grant
    Filed: April 2, 1999
    Date of Patent: May 16, 2006
    Inventors: Michael Catt, Rosie L Habeshaw, Keith May, Fiona McNae, Andrew P Phelan